Troponin Profile Of Clopidogrel And Ticagrelor With Old Generation PPIs In Myocardial Infarction Patients

Erlisa Ika Yuni Pramesti; Kharisma Jayak Pratama; Hidayah Apriliawan

doi:10.55227/ijhet.v4i6.664

Authors

Erlisa Ika Yuni Pramesti Duta Bangsa University, Surakarta
Kharisma Jayak Pratama Duta Bangsa University, Surakarta
Hidayah Apriliawan Duta Bangsa University, Surakarta

DOI:

https://doi.org/10.55227/ijhet.v4i6.664

Keywords:

Clopidogrel, Myocardial Infarction, Proton Pump Inhibitor, Ticagrelor, Troponin

Abstract

Myocardial infarction is a leading cause of cardiovascular death in Indonesia with an increasing prevalence. The interaction of clopidogrel-ticagrelor with older-generation PPIs can affect antiplatelet efficacy and troponin levels. This study aims to describe troponin levels in the use of clopidogrel and ticagrelor with older-generation PPIs and their relationship to patient characteristics and lipid profiles. A retrospective descriptive observational method was conducted on 76 myocardial infarction patients at March eleventh University Hospital (November 2024-November 2025) using medical record data. Univariate (frequency, mean) and bivariate (Chi-Square, p<0.05) analyses were processed using SPSS. The results showed that the majority of patients were male (66%), aged 46-65 years (64%). There was no significant association between gender (p=0.542), age (p=0.415), clopidogrel-PPI (p=0.346), ticagrelor-PPI (p=0.368), and LDL (p=0.100) with troponin, but triglycerides were significantly associated (p=0.040). The average troponin of clopidogrel was 9.465 ng/L, higher than that of ticagrelor (3.879 ng/L). It was concluded that triglycerides significantly influenced troponin, while patient characteristics and the combination of antiplatelet-PPI did not.

Downloads

Download data is not yet available.

References

Ahmed, S.A., Ismail, J., Nafees, T., Faraz, A., Tahir, M., & Rehman, M.U. (2020). Sensitivity and specificity of bedside qualitative troponin I test kit as compared with the standardized quantitative lab test for troponin I. Cureus, 12(4), e7765. https://doi.org/10.7759/cureus.7765

Al Amin, M., & Dwi, J. (2017). Human age group classification based on box counting fractal dimension analysis of facial images with Canny edge detection. Scientific Journal of Mathematics, 2(6), 33–42.

Andayani, A., Prodyanatasari, A., & Oktavia, JM (2024). Correlation of troponin I levels with lipid profile levels in coronary heart disease patients. Jurnal Nusantara Medika, 8(1).https://doi.org/10.29407/judika.v8i1.22581

Ceo, A., et al. (2016). Oxidative stress and cardiovascular aging. Journal of Cardiology Research, 8(3), 112–118.*

Creswell, J. W., & Creswell, J. D. (2022). Research design: Qualitative, quantitative, and mixed methods approaches (6th ed.). Sage Publications.

Darussalam, D., & Muhammad, M. (2017). Relationship between lipid profiles in patients with acute myocardial infarction. Journal of Clinical Medicine, 5(2), 45–52.*

Dewi, MN, & Ratnata, A. (2020). Drug interactions between clopidogrel and proton pump inhibitors (PPIs). Indonesian Journal of Clinical Pharmacy, 1(1), 1–5.

Emzir. (2012). Educational research methodology: Quantitative and qualitative. Rajawali Pers.

Gao, W., Zhang, X., Yin, Y., Yu, S., & Wang, L. (2021). Different doses of new generation proton pump inhibitors for the treatment of Helicobacter pylori infection: A meta-analysis. International Journal of Immunopathology and Pharmacology, 35, 1–10.https://doi.org/10.1177/20587384211030397

Kimenai, D.M., et al. (2020). Influence of age and renal function on troponin levels. Clinical Biochemistry, 83, 27–34.*

Kurniawan, PR, Setiawan, AA, Limantoro, C., & Ariosta, A. (2021). The differences in troponin I and CK-MB values in acute myocardial infarction patients with ST elevation and without ST elevation. Diponegoro Medical Journal, 10(2), 138–144.

Leksana, E., & Ika, CP (2016). Troponin and perioperative myocardial ischemia management. Indonesian Journal of Anesthesiology, 8(2), 75–82.*

Leni. (2024). The role of estrogen in cardiovascular protection in women. Journal of Women's Health, 5(1), 12–18.*

Majid, AA (2017). Nursing care for patients with cardiovascular system disorders. Pustaka Baru Press.

Mendoza, R. (2023). Atherosclerosis and myocardial infarction risk factors. Cardiology Today, 18(4), 211–218.*

Mueller, C., et al. (2018). Clinical use of cardiac troponin in patients with suspected myocardial infarction. European Heart Journal, 39(23), 2032–2041.*

Muhibbah, M., Wahid, A., Agustina, R., & Illiandri, O. (2019). Characteristics of acute coronary syndrome patients in hospitalized patients. Indonesian Journal of Health Sciences, 3(1), 6–12.

Rampengan, SH (2020). The relationship between Helicobacter pylori and left ventricular ejection fraction in patients with acute myocardial infarction. Biomedical Journal, 12(2), 85–92.*

Raharjo, DFA, Magfiroh, IL, & Rokhman, A. (2025). Factors of acute myocardial infarction attacks. Scientific Journal of Nursing, 11(3), 1–10.

Ridker, P.M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., et al. (2017). Cardiovascular efficacy and safety of bococizumab in high-risk patients. New England Journal of Medicine, 376(16), 1527–1539.

Sugiyono. (2021). Quantitative, qualitative, and R&D research methods. Alfabeta.

Sudaryono. (2021). Quantitative, qualitative, and mixed method research methodology. Rajawali Pers.

Valgimigli, M., Bueno, H., Byrne, R.A., et al. (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease. European Heart Journal, 39(3), 213–260.*

Wardah, S. (2023). The relationship between troponin-I and lipid profiles in acute myocardial infarction patients at Gatot Soebroto Army Hospital (Thesis). Mohammad Husni Thamrin University.

Wijaya. (2021). Review of drug interactions of clopidogrel with proton pump inhibitors (PPIs) in the treatment of cardiovascular events. Jurnal Kedokteran Meditek, 27(2), 190–196.

Zaman, NN, & Ajeng, D. (2018). Clinical implications of CYP2C19 genotype polymorphism variations on clopidogrel metabolic response. Pharmaka, 16(2), 89–97.

Zhang, YJ, et al. (2022). Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease. BMC Cardiovascular Disorders, 22, 1–11.https://doi.org/10.1186/s12872-022-02988-w